Ireland · Clinics, agencies, contracts and payments

Editorial illustration of contract pages, a payment schedule, calculator and medical items arranged for a legal risk review.

Ireland surrogacy contracts, clinics, agencies and payments: legal risks

The answer in brief

At 20 October 2026, the main surrogacy provisions of Ireland’s Health (Assisted Human Reproduction) Act 2024 appear not to be in force. The latest official commencement index cited here, updated 24 June 2026, lists sections 6–119 as not yet commenced. A Dáil answer on 13 October 2026 still describes commencement of the Act as a future step, but it does not enumerate individual sections. The available official material therefore indicates that Parts 7 and 8 are not yet operative; recheck any later commencement orders before relying on this status. Do not present the Act as the current code for clinic approval, agency fees, commercial payments or contract enforceability.

A signed agreement, agency promise, clinic advertisement or payment plan does not prove legality, recoverability of funds or recognition of intended parents as legal parents. General law and any foreign law still matter.

What the law currently does — and does not — say

Citizens Information describes domestic and international surrogacy, altruistic or commercial, as not specifically regulated in Ireland at present. It is unsafe to call it simply “legal” or “illegal”: no fully operative surrogacy-specific statutory scheme exists, but general rules on medical practice, consent, contracts, privacy, financial dealings, child protection and activity abroad still apply.

Classify each statement as: (1) commenced law; (2) enacted but uncommenced law; (3) official guidance; or (4) a recommended contractual safeguard. These categories are not interchangeable: a provision in an Act is not necessarily in force.

A contract does not establish parentage

Parentage is a separate risk from the service contract. Current public guidance says the woman who gives birth is the child’s legal mother and guardian even if she did not provide the egg. Under section 46 of the Status of Children Act 1987, the husband is generally presumed to be the father if the woman gives birth during a subsisting marriage or within ten months after its termination, unless the presumption is rebutted. Genetics or a private agreement alone do not automatically replace those rules.

A clinic or agency cannot safely promise that a contract will make intended parents legal parents, produce a birth certificate in their names, confer citizenship or secure travel documents. Before embryo transfer or payment, request a separate written plan for parentage, guardianship, birth registration, nationality and immigration.

What the 2024 Act would do for domestic surrogacy

Part 7 of the Health (Assisted Human Reproduction) Act 2024 (sections 51–69) sets out a future domestic-surrogacy framework. It envisages specified agreement requirements and advance approval by the Assisted Human Reproduction Regulatory Authority (AHRRA), eligibility and suitability checks, counselling, consent and independent legal advice, restrictions on commercial surrogacy, and a limited route for enforcing a surrogate’s qualifying reasonable expenses. Sections 57–59 address commercial payments, qualifying expenses and the general non-enforceability of surrogacy agreements, subject to the statutory expense exception.

Crucial qualification: the official commencement index lists sections 6–119 as not yet commenced. These domestic-surrogacy provisions are a guide to the proposed future framework, not a current ban on a particular payment or a present entitlement to claim reimbursement under those sections. Re-check commencement and any regulations immediately before signing.

Regulator status matters: AHRRA was established under provisions that commenced on 13 October 2025, but the statutory surrogacy-approval procedures in Parts 7 and 8 remain uncommenced. The Authority’s existence does not mean that a particular domestic or international arrangement can currently obtain approval under sections 53 or 90.

International arrangements and intermediaries

Part 8 of the 2024 Act (sections 79–119) proposes a separate system for international surrogacy, including approval of an agreement, conditions for a “permitted international surrogacy”, restrictions on commercial arrangements and recordkeeping. Section 97 envisages using a foreign intermediary only where its services are lawful in the relevant country and its fees are reasonable in the circumstances. Section 98 envisages independent legal advice for the surrogate and the intended parent or parents. These provisions are also not yet commenced.

Irish approval and legality under the foreign country’s law are separate questions. A foreign clinic or agency must comply with the law where it operates; an Irish contract cannot cure a defect under that law. Conversely, a foreign birth certificate or local parentage order does not automatically resolve Irish parentage, citizenship or travel issues.

Quick comparison: legal status and contract controls

IssueLegal positionPractical control
Current frameworkIreland has no operative surrogacy-specific statutory code; ordinary laws still apply.Do not describe an uncommenced Act provision as an existing licence or ban.
Payments to the surrogateSpecific future commercial-surrogacy and expense rules are in the 2024 Act, but sections 57–59 and 93–95 are not yet commenced.Separate proposed reimbursement from remuneration; obtain current-law advice before paying.
Agency or intermediaryFuture section 97 would require international intermediary services to be lawful locally and fees reasonable; it is not yet in force.Verify the legal entity, service scope, local permissions and itemised fee basis.
Agreement and parentageFuture sections 59 and 95 generally limit enforceability, with a defined expense exception; they are not yet in force. A contract does not itself establish parentage.Do not pay on the assumption that signatures guarantee handover, parentage or a refund.

Check the clinic’s actual authorisations

Check the clinic independently, not through the agency’s marketing. If it handles reproductive cells or embryos, ask which legal entity and site performs each activity, and verify whether the site’s tissue-establishment authorisation appears on the Health Products Regulatory Authority (HPRA) current list. HPRA says procurement, testing, processing, preservation, storage and distribution of human tissues or cells may require authorisation. Match the exact site and activity; a brand name is not enough.

An HPRA tissue authorisation is not an AHRRA surrogacy approval, a finding that the arrangement is lawful, or a guarantee of success or parentage. Request clinician registration, the treatment plan, written consent documents, complaint process, relevant storage or import details, and a direct clinic invoice. If the activity falls outside the authorisation or the clinic will not identify the contracting entity, pause and obtain advice.

Authorisation depends on the exact activity and site; do not assume that every clinic needs the same type of authorisation. Regulation (EU) 2024/1938 on substances of human origin is scheduled to replace the current EU tissues-and-cells regime from 7 August 2027. If treatment, storage or import is planned on or after that date, ask HPRA which registration and authorisation requirements will apply rather than relying only on today’s list.

Check the agency as a separate provider

Obtain the agency’s full legal name, registration number, registered address, governing-law clause, complaints route and each subcontractor’s identity. Require a written description of its actual services: matching, coordination, translation, travel, medical liaison, payment administration or legal referrals. Ask which services it provides itself and which it resells.

Request an itemised quote separating agency fees from clinic, surrogate, counselling, legal, donor, travel, accommodation, insurance and translation costs. For each pass-through amount, identify recipient, invoice, currency, due date, markup and refund rule. An unexplained “programme fee” makes it hard to assess reasonableness, detect double charging or recover unused funds. Do not assume the agency has AHRRA approval under provisions not yet in force.

Make every payment traceable

Build the payment plan around evidence and milestones, not pressure. The written schedule should state who receives each payment, what event triggers it, which documents prove that event, whether funds are held by independent escrow or client-money provider, and when unused funds are returned. Define failed-cycle, cancelled-transfer, miscarriage, medical contraindication, surrogate withdrawal, clinic closure, agency breach and force-majeure scenarios. State the refund amount or calculation for each; “refund subject to policy” is not enough.

Keep receipts and bank records. Distinguish reimbursement of actual expenses from compensation, agency remuneration and clinic fees. Future expense provisions in the 2024 Act would require actual, documented expenses, but those sections are not currently operative. Receipts remain prudent; this does not mean the future statutory test already applies.

Do not read the absence of commenced surrogacy-specific payment rules as blanket permission to pay. If an Irish adoption route may be involved, section 145 of the Adoption Act 2010 prohibits payments or rewards in consideration of adoption and payments for making arrangements for adoption, subject to specific statutory exceptions; Citizens Information states that a surrogate mother cannot be paid to place a child for adoption. Whether a proposed expense reimbursement or other transfer falls within those rules depends on its purpose and the facts. The future expense exceptions in sections 58 and 94 of the 2024 Act are not a current safe harbour. Before making any payment linked to an Irish adoption or placement, obtain written Irish legal advice; do not disguise the purpose or route the payment through an intermediary.

Clauses the contract package should cover

Have an independent lawyer review the full contract package before any non-refundable payment. At minimum, the documents should identify and address:

  • All parties and legal entities, including the clinic and site, agency, surrogate, intended parent or parents, escrow holder and subcontractors; specify who is not a party.
  • Exact services and exclusions, treatment steps, number of cycles, clinical decision-maker, donor arrangements, records access and what happens if proposed treatment is unavailable.
  • Total budget, currency, tax and bank charges, each recipient, milestones, receipts, holdback, escrow terms, refund formula, audit rights and no unilateral price changes.
  • Medical consent, independent decision-making and privacy. No clause should purport to force treatment, continuation of pregnancy, abortion, embryo reduction or disclosure of confidential medical information.
  • Cancellation, withdrawal, unsuccessful treatment, multiple pregnancy, complications, disability or death; notice, costs already incurred, insurance and continuing support.
  • Confidentiality and data protection, retention of records, cross-border transfers, access by the child where applicable, and who holds records if a provider closes.
  • Applicable law and dispute forum for each separate agreement, service of notices, negotiation or mediation if desired, remedies for breach and liability limits. Do not assume an Irish clause governs a foreign clinic or surrogate.
  • An express statement that no provider guarantees a live birth, parentage, citizenship, passport, immigration outcome or court order.

Each party should receive the final signed version and all annexes in a language they understand. Do not sign a blank, backdated, incomplete or inconsistent contract. Changes to payment terms or services should be written and signed by all affected parties.

Consent, withdrawal and failed treatment

Consent and bodily autonomy are not ordinary deliverables. A contract should not claim that money buys control over a surrogate’s medical decisions or guarantees that a child will be handed over. Future section 59 of the 2024 Act expressly protects a surrogate’s rights concerning her pregnancy and medical privacy, but that section is not yet in force; valid clinical consent remains a separate issue from contract wording. Independent legal advice for the surrogate, from a lawyer who does not act for the agency or intended parents, is a strong safeguard even before the future provisions commence.

Agree how urgent medical decisions, communication, expenses, loss of income, counselling and postpartum support will be handled without giving intended parents or an agency control over treatment. A dispute or withdrawal should trigger legal advice and a safe plan for the child and surrogate, not threats, self-help or withholding essential care.

Cross-border arrangements need two legal reviews

Use two separate legal reviews: one by a lawyer qualified where the surrogate, clinic and embryo transfer are located, and one by Irish family-law counsel. Confirm that the proposed procedure and agency services are lawful locally. Obtain a written view of the parentage route, birth registration, travel document, citizenship and immigration steps for the child. Ask what happens if local law changes, a court refuses an order, DNA evidence is requested or one parent cannot travel.

Do not assume that an Irish citizen, resident or intended parent automatically qualifies under the future Act’s international route; its criteria are not yet operative and must be checked if the Act commences. Do not promise a fixed return date before the competent authorities confirm the child’s documents and status.

Documents to collect before signing

Collect before signing:

  • The complete proposed agreement and every annex.
  • Corporate registration details for each provider.
  • Clinic and relevant HPRA authorisation evidence.
  • Itemised quotes and payment/refund schedules.
  • Draft agreements with the surrogate, clinic, agency and escrow holder.
  • Insurance terms and a written explanation of uncovered costs.
  • Consent, counselling and recordkeeping plans.
  • Local-country legal advice and the Irish parentage/travel plan.
  • Translations of every document the parties must understand.

Store receipts, messages, invoices, consent forms, treatment records and signed versions securely. Keep a dated record of promises made in calls or messages and ask for them to be included in the contract if they affect price, refunds or outcomes.

A safe order of action before the next payment

Before paying, proceed in this order:

  • Identify whether the plan is domestic or international and where each medical act occurs.
  • Ask an Irish surrogacy or family-law solicitor independent of the agency to map current parentage rules and remedies.
  • Obtain local-country counsel if any step occurs abroad.
  • Verify the clinic’s legal entity, professional credentials and relevant HPRA authorisation.
  • Reconcile the budget against every contract and invoice.
  • Negotiate staged payments, proof of expenditure, independent handling of client money and event-specific refunds.
  • Check the official commencement index again on the date of signature.

If a provider refuses to disclose recipients, will not allow independent advice or insists on immediate irreversible payment before documents are available, pause. Do not transfer funds merely to preserve a quoted price or appointment.

Red flags that justify pausing

Red flags include a guaranteed Irish birth certificate, citizenship or passport; a claim that the 2024 Act already makes an agency “AHRRA-approved”; unexplained lump-sum charges; cash or third-party payments without receipts; a refund promise with no formula; the agency’s lawyer advising the surrogate and intended parents together; pressure to misstate the genetic parent, destination or purpose of a payment; no access to the actual clinic contract; or a clause allowing the provider to change prices unilaterally. Any one of these warrants written clarification and independent advice before proceeding.

Practical conclusion

Ireland’s 2024 Act contains a detailed proposed surrogacy framework, but the official commencement material shows that its main provisions remain uncommenced as of 20 October 2026. Do not rely on future statutory rules as if they already govern your agreement. Verify clinic authorisations where relevant, separate the agency’s role from medical and legal services, document every payment, and obtain independent Irish and, if needed, foreign legal advice. No contract can guarantee parentage, a refund or an immigration outcome. Re-check the law immediately before signing or transferring funds.

Sources and legal-status notes

  1. S1 — Irish Statute Book — commencement status of the Health (Assisted Human Reproduction) Act 2024
  2. S2 — Oireachtas — Dáil answer, 13 October 2026, Question 616
  3. S3 — Citizens Information — Surrogacy in Ireland
  4. S4 — Status of Children Act 1987, section 46 — Irish Statute Book
  5. S5 — HPRA — Our role in regulating tissues and cells
  6. S6 — HPRA — Tissue establishment list
  7. S7 — Health (Assisted Human Reproduction) Act 2024 — enacted text
  8. S8 — Health (Assisted Human Reproduction) Act 2024, section 97 — Role of intermediaries
  9. S9 — Adoption Act 2010, section 145 — Irish Statute Book
  10. S10 — HPRA — SoHO Regulation: Scope and Key Changes from Previous Legislation

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards